Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 35.33% is 69% above its 5-year average of 20.91%, near the high end of its 5-year range (-7.12%–40.85%).
1.56% above its 12-month average of 34.79%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-07-03): 33.73%.
NET PROFIT MARGIN
35.33%
NET PROFIT MARGIN AVG TTM
34.79%
NET PROFIT MARGIN AVG 3Y
28.30%
NET PROFIT MARGIN AVG 5Y
20.91%
NET PROFIT MARGIN AVG 10Y
25.97%
NET PROFIT MARGIN AVG 15Y
-67.63%
NET PROFIT MARGIN AVG 20Y
-22.50%
CURRENT VS TTM AVG
+1.56%
CURRENT VS 3Y AVG
+24.83%
CURRENT VS 5Y AVG
+69.00%
CURRENT VS 10Y AVG
+36.06%
CURRENT VS 15Y AVG
+152.24%
CURRENT VS 20Y AVG
+257.04%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 373 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Exelixis, Inc.
Market Cap
$14.79B
Net Profit Margin
35.33%
TTM Avg
34.79%
3Y Avg
28.30%
5Y Avg
20.91%
Market Cap
$14.64B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$14.97B
Net Profit Margin
-5.96%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
Market Cap
$15.24B
Net Profit Margin
17.26%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$14.16B
Net Profit Margin
71.08%
TTM Avg
-67.82%
3Y Avg
-363.95%
5Y Avg
-2068.81%
Market Cap
$13.19B
Net Profit Margin
6.61%
TTM Avg
16.89%
3Y Avg
20.26%
5Y Avg
23.62%
Market Cap
$12.95B
Net Profit Margin
-97.64%
TTM Avg
-193.35%
3Y Avg
-1980.08%
5Y Avg
-2361.16%
Market Cap
$12.89B
Net Profit Margin
3.99%
TTM Avg
6.17%
3Y Avg
6.60%
5Y Avg
6.82%
Market Cap
$12.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exelixis, Inc. (EXEL) | $14.79B | 35.33% | 34.79% | 28.30% | 20.91% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -17.77% | -60.53% | -62.93% | -77.31% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | -5.96% | -1.67% | 5.09% | 7.31% |
| Solventum Corporation (SOLV)vs › | $15.24B | 17.26% | 12.25% | 14.36% | 15.15% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 71.08% | -67.82% | -363.95% | -2068.81% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 6.61% | 16.89% | 20.26% | 23.62% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -97.64% | -193.35% | -1980.08% | -2361.16% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.99% | 6.17% | 6.60% | 6.82% |
| Baxter International Inc. (BAX)vs › | $12.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.67% | 6.92% | 5.54% | 3.35% |
Operating Margin
39.9%
Net Profit Margin
35.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-03 | 33.73% |
| 2026-04-03 | 34.46% |
| 2026-01-02 | 40.85% |
| 2025-10-03 | 32.38% |
| 2025-07-04 | 32.53% |
| 2025-04-04 | 28.74% |
| 2024-12-31 | 24.68% |
| 2024-09-27 | 21.87% |
| 2024-06-28 | 35.49% |
| 2024-03-29 | 8.78% |
| 2023-12-31 | 17.83% |
| 2023-09-29 | 0.22% |
| 2023-06-30 | 17.28% |
| 2023-03-31 | 9.79% |
| 2022-12-31 | -7.12% |
| 2022-09-30 | 17.78% |
| 2022-07-01 | 16.85% |
| 2022-04-01 | 19.26% |
| 2021-12-31 | 21.09% |
| 2021-10-01 | 11.63% |
| 2021-07-02 | 24.95% |
| 2021-04-02 | 0.59% |
| 2020-12-31 | 10.51% |
| 2020-10-02 | -13.86% |
| 2020-07-03 | 25.75% |
| 2020-04-03 | 21.42% |
| 2019-12-31 | 28.61% |
| 2019-09-27 | 35.87% |
| 2019-06-28 | 32.90% |
| 2019-03-29 | 35.16% |
| 2018-12-31 | 157.52% |
| 2018-09-28 | 56.18% |
| 2018-06-29 | 47.01% |
| 2018-03-30 | 54.56% |
| 2017-12-31 | 32.05% |
| 2017-09-29 | 53.36% |
| 2017-06-30 | 17.83% |
| 2017-03-31 | 20.65% |
| 2016-12-31 | 45.27% |
| 2016-09-30 | -18.14% |
| 2016-07-01 | -102.10% |
| 2016-04-01 | -397.66% |
| 2015-12-31 | -439.13% |
| 2015-10-02 | -482.69% |
| 2015-07-03 | -542.57% |
| 2015-04-03 | -374.63% |
| 2014-12-31 | -788.15% |
| 2014-09-26 | -994.44% |
| 2014-06-27 | -1118.71% |
| 2014-03-28 | -1521.28% |
| 2013-12-31 | -1627.47% |
| 2013-09-27 | -1228.03% |
| 2013-06-28 | -524.30% |
| 2013-03-29 | -462.60% |
| 2012-12-31 | -667.94% |
| 2012-09-30 | -246.48% |
| 2012-06-29 | -467.00% |
| 2012-03-30 | -141.28% |
| 2011-12-31 | 49.62% |
| 2011-09-30 | 60.70% |
| 2011-07-01 | -65.22% |
| 2011-04-01 | -76.59% |
| 2010-12-31 | -43.81% |
| 2010-10-01 | -15.79% |
| 2010-07-02 | -47.51% |
| 2010-04-02 | -102.49% |
| 2009-12-31 | -65.42% |
| 2009-10-02 | -46.28% |
| 2009-07-03 | -163.35% |
| 2009-04-03 | -142.99% |
| 2008-12-31 | -128.33% |
| 2008-09-26 | -128.64% |
| 2008-06-27 | -148.38% |
| 2008-03-28 | -147.70% |
| 2007-12-31 | -68.11% |
| 2007-09-28 | -51.06% |
| 2007-06-29 | -97.62% |
| 2007-03-30 | -86.01% |
| 2006-12-31 | -84.59% |
| 2006-09-30 | -107.04% |
| 2006-06-30 | -88.07% |
| 2006-03-31 | -149.69% |
| 2005-12-31 | -170.56% |
| 2005-09-30 | -158.16% |
| 2005-06-30 | -28.26% |
| 2005-03-31 | -212.92% |
| 2004-12-31 | -329.79% |
| 2004-09-30 | -214.73% |
| 2004-06-30 | -233.23% |
| 2004-03-31 | -242.54% |
| 2003-12-31 | -169.11% |
| 2003-09-30 | -200.94% |
| 2003-06-30 | -180.25% |
| 2003-03-31 | -187.01% |
| 2002-12-31 | -167.53% |
| 2002-09-30 | -219.97% |
